6.91
price down icon10.49%   -0.81
after-market Handel nachbörslich: 7.04 0.13 +1.88%
loading
Schlusskurs vom Vortag:
$7.72
Offen:
$7.7
24-Stunden-Volumen:
1.45M
Relative Volume:
4.14
Marktkapitalisierung:
$408.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-153.16M
KGV:
-1.8726
EPS:
-3.69
Netto-Cashflow:
$-134.48M
1W Leistung:
-9.20%
1M Leistung:
-12.97%
6M Leistung:
-15.01%
1J Leistung:
-63.01%
1-Tages-Spanne:
Value
$6.61
$7.70
1-Wochen-Bereich:
Value
$6.61
$7.82
52-Wochen-Spanne:
Value
$6.61
$19.66

Cullinan Therapeutics Inc Stock (CGEM) Company Profile

Name
Firmenname
Cullinan Therapeutics Inc
Name
Telefon
617-410-4650
Name
Adresse
ONE MAIN STREET, CAMBRIDGE
Name
Mitarbeiter
111
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
CGEM's Discussions on Twitter

Vergleichen Sie CGEM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CGEM
Cullinan Therapeutics Inc
6.91 442.47M 0 -153.16M -134.48M -3.69
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Cullinan Therapeutics Inc Stock (CGEM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-21 Fortgesetzt H.C. Wainwright Buy
2025-06-11 Fortgesetzt Stifel Buy
2024-10-24 Eingeleitet UBS Buy
2024-05-01 Eingeleitet Stifel Buy
2024-04-15 Eingeleitet William Blair Outperform
2024-02-15 Eingeleitet Wedbush Outperform
2023-06-15 Eingeleitet TD Cowen Outperform
2022-11-21 Eingeleitet BTIG Research Buy
2021-04-27 Hochstufung Morgan Stanley Equal-Weight → Overweight
2021-02-02 Eingeleitet Evercore ISI Outperform
2021-02-02 Eingeleitet Morgan Stanley Equal-Weight
2021-02-02 Eingeleitet SVB Leerink Outperform
2021-02-01 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Cullinan Therapeutics Inc Aktie (CGEM) Neueste Nachrichten

pulisher
Sep 03, 2025

Is Cullinan Therapeutics Inc. stock trending bullishWeekly Trading Summary & AI Driven Stock Movement Reports - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Analyzing drawdowns of Cullinan Therapeutics Inc. with statistical toolsPortfolio Growth Summary & Long-Term Growth Stock Strategies - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What institutional flow reveals about Cullinan Therapeutics Inc.July 2025 Action & Weekly Setup with High ROI Potential - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Chart based analysis of Cullinan Therapeutics Inc. trendsEarnings Beat & High Conviction Buy Zone Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to use Fibonacci retracement on Cullinan Therapeutics Inc.2025 Market Outlook & Fast Entry and Exit Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Live market analysis of Cullinan Therapeutics Inc.Quarterly Profit Review & Free Expert Approved Momentum Trade Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Real time scanner hits for Cullinan Therapeutics Inc. explainedPortfolio Gains Report & Daily Technical Forecast Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Order flow analysis tools used on Cullinan Therapeutics Inc.New Guidance & Safe Entry Trade Reports - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Is this a good reentry point in Cullinan Therapeutics Inc.Bond Market & Weekly High Potential Stock Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Cullinan Therapeutics Inc. meeting your algorithmic filter criteria2025 Volume Leaders & Long-Term Growth Stock Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Will Cullinan Therapeutics Inc. benefit from government policyMarket Movement Recap & Long-Term Safe Investment Plans - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Can Cullinan Therapeutics Inc. hit a new high this monthJuly 2025 Weekly Recap & Stock Portfolio Risk Control - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Real time alert setup for Cullinan Therapeutics Inc. performanceWeekly Trade Analysis & Verified Trade Idea Suggestions - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What the charts say about Cullinan Therapeutics Inc. today2025 Earnings Surprises & Daily Technical Stock Forecast Reports - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Short Interest Drops in Cullinan Therapeutics Inc. After RallyProfit Target & Consistent Profit Trade Alerts - beatles.ru

Sep 02, 2025
pulisher
Sep 02, 2025

Chart overlay techniques for tracking Cullinan Therapeutics Inc.Bear Alert & Technical Analysis for Trade Confirmation - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Update Recap: Why is Cullinan Therapeutics Inc. stock going upJuly 2025 Breakouts & Free Real-Time Market Sentiment Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

Pattern recognition hints at Cullinan Therapeutics Inc. upsideWeekly Trading Summary & Expert Verified Movement Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Measuring Cullinan Therapeutics Inc.’s beta against major indicesMarket Performance Summary & Fast Exit and Entry Trade Guides - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Fibonacci Retracement Aligns with Support in Cullinan Therapeutics Inc.July 2025 Movers & AI Forecast Swing Trade Picks - beatles.ru

Sep 01, 2025
pulisher
Sep 01, 2025

What Technical Tools Say About Cullinan Therapeutics Inc. Recovery getLinesFromResByArray error: size == 0 - kangso.co.kr

Sep 01, 2025
pulisher
Sep 01, 2025

Is now the right time to enter Cullinan Therapeutics Inc.July 2025 Gainers & Weekly Consistent Profit Watchlists - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Is Cullinan Therapeutics Inc. on track to beat earningsPortfolio Profit Report & Low Risk Entry Point Guides - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Is Cullinan Therapeutics Inc. showing signs of accumulationJuly 2025 Movers & Smart Allocation Stock Reports - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Is it too late to sell Cullinan Therapeutics Inc.2025 Earnings Impact & Consistent Return Investment Signals - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Analyzing net buyer seller activity in Cullinan Therapeutics Inc.July 2025 PostEarnings & Verified Short-Term Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using AI based signals to follow Cullinan Therapeutics Inc.Layoff News & Stock Timing and Entry Methods - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is Cullinan Therapeutics Inc. stock ready for a breakout2025 Historical Comparison & Fast Gain Stock Trading Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is Cullinan Therapeutics Inc. stock poised for growthMarket Weekly Review & Safe Entry Momentum Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Published on: 2025-08-31 01:54:17 - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Cullinan Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Published on: 2025-08-30 20:25:19 - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Fibonacci Retracement Aligns with Support in Cullinan Therapeutics Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스

Aug 30, 2025
pulisher
Aug 30, 2025

How to build a custom watchlist for Cullinan Therapeutics Inc.Dividend Hike & Consistent Income Trade Ideas - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Can Cullinan Therapeutics Inc. ride the EV waveMarket Sentiment Summary & Consistent Profit Trading Strategies - sundaytimes.kr

Aug 30, 2025

Finanzdaten der Cullinan Therapeutics Inc-Aktie (CGEM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Cullinan Therapeutics Inc-Aktie (CGEM) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
AHMED NADIM
President and CEO
Feb 25 '25
Sale
8.53
12,529
106,872
430,621
Michaelson Jennifer
Chief Scientific Officer
Feb 25 '25
Sale
8.53
3,756
32,039
142,004
SUMER JACQUELYN L
Chief Legal Officer
Feb 25 '25
Sale
8.53
3,756
32,039
136,895
Michaelson Jennifer
Chief Scientific Officer
Jan 06 '25
Sale
12.51
4,000
50,040
95,760
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):